Compare VIOT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIOT | IXHL |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 134.7M |
| IPO Year | 2018 | N/A |
| Metric | VIOT | IXHL |
|---|---|---|
| Price | $1.42 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 345.7K | ★ 7.8M |
| Earning Date | 03-24-2026 | 02-13-2026 |
| Dividend Yield | ★ 5.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $385,267,177.00 | $12,000.00 |
| Revenue This Year | $42.19 | N/A |
| Revenue Next Year | $0.96 | N/A |
| P/E Ratio | $3.53 | ★ N/A |
| Revenue Growth | ★ 16.89 | N/A |
| 52 Week Low | $1.18 | $0.08 |
| 52 Week High | $4.33 | $2.24 |
| Indicator | VIOT | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 41.09 | 36.13 |
| Support Level | $1.30 | $0.25 |
| Resistance Level | $1.42 | $0.30 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 93.10 | 26.04 |
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.